Anixa Biosciences Inc (ANIX)
2.85
-0.06
(-2.06%)
USD |
NASDAQ |
May 17, 16:00
2.86
+0.01
(+0.35%)
After-Hours: 20:00
Anixa Biosciences Price to Book Value: 3.695 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.695 |
| May 16, 2024 | 3.773 |
| May 15, 2024 | 3.799 |
| May 14, 2024 | 3.864 |
| May 13, 2024 | 3.850 |
| May 10, 2024 | 3.889 |
| May 09, 2024 | 3.721 |
| May 08, 2024 | 3.915 |
| May 07, 2024 | 3.773 |
| May 06, 2024 | 3.915 |
| May 03, 2024 | 3.812 |
| May 02, 2024 | 3.850 |
| May 01, 2024 | 4.006 |
| April 30, 2024 | 3.850 |
| April 29, 2024 | 3.915 |
| April 26, 2024 | 4.188 |
| April 25, 2024 | 3.864 |
| April 24, 2024 | 4.123 |
| April 23, 2024 | 3.980 |
| April 22, 2024 | 3.902 |
| April 19, 2024 | 4.045 |
| April 18, 2024 | 4.019 |
| April 17, 2024 | 3.954 |
| April 16, 2024 | 4.110 |
| April 15, 2024 | 4.097 |
| Date | Value |
|---|---|
| April 12, 2024 | 4.110 |
| April 11, 2024 | 4.175 |
| April 10, 2024 | 4.149 |
| April 09, 2024 | 4.214 |
| April 08, 2024 | 4.110 |
| April 05, 2024 | 4.149 |
| April 04, 2024 | 4.071 |
| April 03, 2024 | 4.252 |
| April 02, 2024 | 4.149 |
| April 01, 2024 | 4.343 |
| March 28, 2024 | 4.045 |
| March 27, 2024 | 4.188 |
| March 26, 2024 | 4.058 |
| March 25, 2024 | 4.188 |
| March 22, 2024 | 4.486 |
| March 21, 2024 | 4.784 |
| March 20, 2024 | 4.836 |
| March 19, 2024 | 4.667 |
| March 18, 2024 | 4.551 |
| March 15, 2024 | 4.784 |
| March 14, 2024 | 3.993 |
| March 13, 2024 | 4.123 |
| March 12, 2024 | 3.993 |
| March 11, 2024 | 4.168 |
| March 08, 2024 | 4.194 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.220
Minimum
Mar 15 2022
16.31
Maximum
Jul 31 2019
6.59
Average
4.799
Median
Dec 05 2023
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.806 |
Price to Book Value Related Metrics
| Price | 2.85 |
| Earnings Yield | -11.93% |
| Market Cap | 90.91M |